Novartis Bioventures Ltd Aeglea Bio Therapeutics, Inc. (AGLE) insider trading activity

Novartis Bioventures LTD is of Aeglea BioTherapeutics, Inc.. Currently has a direct ownership of 2.18 Million shares of AGLE, which is worth approximately $60.2 Million. The most recent transaction as insider was on May 11, 2018, when has been sold 19,550 shares (Common Stock) at a price of $10.06 per share, resulting in proceeds of $196,673. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.18M

0% 3M change

0% 12M change

Total Value Held $60.2 Million

Novartis Bioventures Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 11 2018	SELL Open market or private sale	$196,673 $10.06 p/Share	19,550 Reduced 0.89%	2,175,314 Common Stock
May 10 2018	SELL Open market or private sale	$230,204 $10.13 p/Share	22,725 Reduced 1.02%	2,194,864 Common Stock
May 09 2018	SELL Open market or private sale	$517,935 $10.11 p/Share	51,230 Reduced 2.26%	2,217,589 Common Stock
May 08 2018	SELL Open market or private sale	$266,367 $10.03 p/Share	26,557 Reduced 1.16%	2,268,819 Common Stock
May 07 2018	SELL Open market or private sale	$157,190 $10.11 p/Share	15,548 Reduced 0.67%	2,295,376 Common Stock
Apr 12 2016	BUY Open market or private purchase	$3,000,000 $10.0 p/Share	300,000 Added 11.49%	2,310,924 Common Stock
Apr 12 2016	BUY Conversion of derivative security	-	2,010,924 Added 50.0%	2,010,924 Common Stock

Also insider at

BCYC

BICYCLE THERAPEUTICS plc Healthcare

> 10% Shareholder

ALT

Altimmune, Inc. Healthcare

> 10% Shareholder

AADI

Aadi Bioscience, Inc. Healthcare

> 10% Shareholder

AKUS

Akouos, Inc. Healthcare

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

GRTX

Galera Therapeutics, Inc. Healthcare

ALRN

AILERON THERAPEUTICS INC Healthcare

> 10% Shareholder

YMTX

YUMANITY THERAPEUTICS, INC. Healthcare

> 10% Shareholder

ATRX

Adhera Therapeutics, Inc. Healthcare

> 10% Shareholder

RARX

Ra Pharmaceuticals, Inc.

> 10% Shareholder

NBL